Jeffrey W. Nix, M.D.
Clinical Subspecialty and Areas of Interest
Education and Degrees
University of Kentucky School of Medicine, M.D.
University of North Carolina, Chapel Hill, Internship
University of North Carolina, Chapel Hill, Residency
National Cancer Institute, Urologic Oncology Fellowship
Awards and HonorsNorth Carolina Urology Resident Seminar, First Prize, Debate Format, 2009
North Carolina Urology Resident Seminar, Third Prize, Research, 2008
North Carolina Urology Resident Seminar, Third Prize, Case Report, 2007
Phi Beta Kappa, 2002
Cum laude, The University of Alabama, 2002
Siddiqui MM, Rais-Bahrami S, Stamatakis L, Vourganti S, Nix JW, Hoang AN, Walton-Diaz A, Weintraub M, Logan J, Sterling T, Truong H, Turkbey B, Choyke P, Wood BJ, Pinto PA. (in press) MRI/Ultrasound fusion biopsy significantly upgrades prostate cancer versus systemic 12-core TRUS biopsy. Eur Urol
Stamatakis L, Siddiqui MM, Nix JW, Logan J, Rais-Bahrami S, Walton-Diaz A, Hoang A, Vourganti S, Truong H, Shuch B, Parnes H, Turkbey B, Choyke P, Wood B, Simon RM, Pinto PA. (in press) Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer. Cancer.
Partanen A, Yerram NK, Trivedi H, Dreher MR, Oila J, Hoang AN, Volkin D, Nix J, Turkbey B, Bernardo M, Haines DC, Benjamin CI, Linehan WM, Choyke P, Wood BI, Ehnholm GI, Venkatesan AM, Pinto PA. Magnetic resonance imaging (MRI)-guided transurethral ultrasound therapy of the prostate: a preclinical study with radiological and pathological correlation using custmoised MRI-based moulds. BJU Int 2013. June 7:
Shuch B, Hofmann JN, Merino MJ, Nix JW, Vourganti S, Linehan WM, Schwarts K, Ruterbusch JJ, Colt JS, Purdue MP, Chow WH. Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results Program. Urol Oncol 2013 Feb 28: S1078-1439.
Volkin D, Yerram N, Ahmed F, Lankford D, Baccala A, Gupta G, Hong A, Nix JW, Metwalli AR, Lang DM, Bratslavsky G, Linehan WM, Pinto P. Partial adrenelectomy minimizes the need for long-term hormone replacement in pediatric patients with pheochromocytoma and von hippel-lindau syndrome. J Pediatr Surg 2012 Nov;47(11):2077-82.
Yerram NK, Volkin D, Turkbey B, Nix J, Hoang AN, Vourganti S, Gupta GN, Linehan WM, Choyke PL, Wood BJ, Pinto PA. Low Suspicion Lesions on Multiparametric Magnetic Resonance Imaging Predict for the Absence of High Risk Prostate Cancer. BJU Int 2012. Nov;6:1464-410x
Hoang AN, Volkin D, Yerram NK, Vourganti S, Nix J, Linehan WM, Wood B, Pinto PA. Image guidance in the focal treatment of prostate cancer. Curr Opin Urol. 2012. Jul;22(4):328-35.
Nix JW, Turkbey B, Hoang A, Volkin D, Yerram N, Chua C, Linehan WM, Wood B, Choyke P, Pinto PA. Very distal apical prostate tumors: identification on multiparametric MRI at 3 Tesla. BJU int 2012 Oct;4: 1464-410
Vourganti S, Rastinehad A, Yerram NK, Nix J, Volkin D, Hoang A, Turkbey B, Gupta GN, Kruecker J, Linehan WM, Choyke PL, Wood BJ, Pinto PA. Multiparametric Magnetic Resonance Imaging and Ultrasound Fusion Biopsy Detects Prostate Cancer in Patients with Prior Negative transrectal ultrasound biopsies. J Urol. 2012 Oct 17; 4482-5.
Pruthi RS, Nix J, McRackan D, Hickerson A, Nielsen ME, Raynor M, Wallen EM. Robotic-assisted laparoscopic intracorporeal urinary diversion. Eur Urol. 2010 Jun;57(6):1013-21.
Pruthi RS, Nielsen ME, Nix J, Smith A, Schultz H, Wallen EM. Robotic radical cystectomy for bladder cancer: surgical and pathological outcomes in 100 consecutive cases. J Urol. 2010 Feb;183(2):510-4.
Nix J, Smith A, Kurpad R, Nielsen ME, Wallen EM, Pruthi RS.. Prospective randomized controlled trial of robotic versus open radical cystectomy for bladder cancer: perioperative and pathologic results. Eur Urol. 2010 Feb;57(2):196-201.
Pruthi RS, Nielsen M, Smith A, Nix J, Schultz H, Wallen EM. Fast track program in patients undergoing radical cystectomy: results in 362 consecutive patients. J Am Coll Surg. 2010 Jan;210(1):93-9.
Nix J, Pruthi RS. Editorial comment. Significance of distal ureteral margin at radical cystectomy for urothelial carcinoma. J Urol 2010. Jan;183(1):81-6..
Raynor MC, Carson CC, Pearson MD, Nix JW. Androgen deficiency in the aging male: A guide to diagnosis and testosterone replacement therapy. Can J Urol. 2007; Dec 14; Suppl 11:63-8.
Nix JW, Carson CC. Medical management of benign prostatic hypertrophy. Can J Urol. 2007; Dec 14; Suppl 1:53-7.
Dr. Nix has experience in the treatment of all types of urologic malignancies. We have highlighted a few of those areas here:
· Surgical and non-surgical treatment of prostate cancer offering robotic surgery for primary or salvage treatment. He also has a very active clinical and research interest in active surveillance for low risk prostate cancer with the incorporation of advanced imaging technology and image guided biopsies of the prostate.
· Treatment of early stage kidney tumors by partial nephrectomy (partial removal of the kidney) or active surveillance as well as radical surgery for locally advanced kidney cancers.
· Treatment of patients with superficial as well as high-grade locally invasive bladder cancer with the incorporation of intravesical therapy as well as robotic/minimally invasive cystectomy and urinary diversions when indicated.
· Evaluation and treatment of adrenal lesions
Having extensive experience in open, laparoscopic, and robotic surgical techniques, Dr. Nix’s surgical approach is based upon individual evaluation of the patient’s tumors and selection of the proper technique for optimal cancer control. While minimally invasive approaches are appropriate for the vast majority of patients, in those for whom they are not Dr. Nix has great comfort level in offering conventional surgical approaches to maximize the likelihood of successful treatment and minimize the risk of complication.